Isolated Gastric Myeloid Sarcoma: A Case Report and Review of the Literature

por Vachhani, Pankit, Bose, Prithviraj
Publicado 2014

Rational Combinations of Targeted Agents in AML

por Bose, Prithviraj, Grant, Steven
Publicado 2015

Recent therapeutic advances in chronic lymphocytic leukemia

por Bose, Prithviraj, Gandhi, Varsha
Publicado 2017

Ruxolitinib for essential thrombocythemia?

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2017

Updates in the management of polycythemia vera and essential thrombocythemia

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2019

JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2020

Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors

por Bose, Prithviraj, Gandhi, Varsha
Publicado 2021

MF management

por Bose, Prithviraj, Verstovsek, Srdan
Publicado 2019

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

por Chifotides, Helen T., Verstovsek, Srdan, Bose, Prithviraj
Publicado 2023

Coordinate PI3K pathway and Bcl-2 family disruption in AML

por Bose, Prithviraj, Rahmani, Mohamed, Grant, Steven
Publicado 2012

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

por Bose, Prithviraj, Masarova, Lucia, Verstovsek, Srdan
Publicado 2020

Momelotinib: an emerging treatment for myelofibrosis patients with anemia

por Chifotides, Helen T., Bose, Prithviraj, Verstovsek, Srdan
Publicado 2022

Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations

por Lovell, Alexandra R., Jammal, Nadya, Bose, Prithviraj
Publicado 2022

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy

por Dinnel, Jennifer, Moore, Bonny L, Skiver, Brent M, Bose, Prithviraj
Publicado 2015

Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

por Alhuraiji, Ahmad, Naqvi, Kiran, Huh, Yang O., Ho, Coty, Verstovsek, Srdan, Bose, Prithviraj
Publicado 2017

Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications

por Gerds, Aaron T., Bose, Prithviraj, Hobbs, Gabriela S., Kuykendall, Andrew T., Neilson, Lynn M., Song, Jinlin, Klencke, Barbara, Harrison, Claire N.
Publicado 2022

Delayed inflammatory pulmonary syndrome: A distinct clinical entity in the spectrum of inflammatory syndromes in COVID-19 infection?

por Bose, Prithviraj, Chacko, Binila, Arul, Ashwin Oliver, Robinson Vimala, Leena, Thangakunam, Balamugesh, Varghese, George M, Jambugulam, Mohan, Lenin, Audrin, Peter, John Victor
Publicado 2023

P1037: CONSISTENCY OF PACRITINIB FOR SPLEEN AND SYMPTOM REDUCTION IN PATIENTS WITH MYELOFIBROSIS REGARDLESS OF CYTOPENIAS

por Gagelmann, Nico, Gupta, Vikas, Mclornan, Donal P, Bose, Prithviraj, Vachhani, Pankit, Kathrin Al-Ali, Haifa, Ali, Haris, Treskes, Philipp, Buckley, Sarah, Roman-Torres, Karisse, Scott, Bart
Publicado 2023

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells

por Rozovski, Uri, Harris, David M., Li, Ping, Liu, Zhiming, Jain, Preetesh, Manshouri, Taghi, Veletic, Ivo, Ferrajoli, Alessandra, Bose, Prithviraj, Thompson, Phillip, Jain, Nitin, Verstovsek, Srdan, Wierda, William, Keating, Michael J., Estrov, Zeev
Publicado 2021

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells

por Fiskus, Warren, Manshouri, Taghi, Birdwell, Christine, Mill, Christopher P., Masarova, Lucia, Bose, Prithviraj, Kadia, Tapan M., Daver, Naval, DiNardo, Courtney D., Borthakur, Gautam, Khoury, Joseph D., Verstovsek, Srdan, Bhalla, Kapil N.
Publicado 2022